Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Photo illustration by Alexander Castro/Rhode Island Current) Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state Medicaid program
In pre-marketing clinical studies of brand-name Wellbutrin SR (sustained-release bupropion) in the treatment of major depressive disorder, mild weight loss of greater than five pounds occurred in 28% of all patients receiving the medication at either a dose of 300 mg per day or 400 mg per day
Azucena Herrera Chancay, M.D., Internal Medicine fellow
By activating both GLP-1 and GIP receptors simultaneously, tirzepatide reduces appetite, enhances insulin sensitivity, slows digestion for prolonged fullness, and may even increase calorie burning
Choline for GLP-1 Support With reduced food intake, the intake of choline an essential nutrient that supports liver fat metabolism, cognitive function, and overall metabolic health can also diminish
